» Authors » Ashley I Martinez

Ashley I Martinez

Explore the profile of Ashley I Martinez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 56
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Badour C, Martinez A, Hood C, Moga D, Moloney M
J Health Care Poor Underserved . 2023 Nov; 34(3):1060-1069. PMID: 38015137
Appalachian women face significant health disparities and have limited access to health care. Mental health conditions and treatment-seeking are stigmatized in Appalachian communities. Appalachian women may benefit from web-based interventions...
2.
Santos C, Tseng M, Martinez A, Shankaran S, Hodgson H, Ahmad F, et al.
Infect Control Hosp Epidemiol . 2023 Oct; 45(3):335-342. PMID: 37877166
Objective: We sought to determine whether increased antimicrobial use (AU) at the onset of the coronavirus disease 2019 (COVID-19) pandemic was driven by greater AU in COVID-19 patients only, or...
3.
Trick W, Santos C, Welbel S, Tseng M, Zhang H, Donceras O, et al.
Infect Control Hosp Epidemiol . 2023 Apr; 44(5):854-855. PMID: 37102459
No abstract available.
4.
Smith N, Martinez A, Huffmyer M, Eckmann L, George R, Abner E, et al.
BMC Geriatr . 2023 Mar; 23(1):137. PMID: 36894900
Background: Polypharmacy and inappropriate medications may be a modifiable risk factor for Alzheimer's Disease and Related Dementias (ADRD). Medication therapy management (MTM) interventions may mitigate medication-induced cognitive dysfunction and delay...
5.
Santos C, Martinez A, Won S, Varughese C, Tseng M, Zhang H, et al.
Transpl Infect Dis . 2022 Oct; 24(5):e13924. PMID: 36254516
Background: Current methods for benchmarking inpatient antimicrobial use (AU) could benefit from combining AU with antimicrobial resistance (AR) information to provide metrics benchmarked to microbiological data; this may yield more...
6.
Wallem A, Martinez A, Vickers L, Singleton M, Moga D
Explor Res Clin Soc Pharm . 2022 Apr; 3:100058. PMID: 35480611
Background: There is currently insufficient data describing how new medications are provided to older adult ambulatory patients with dementia in the United States (US). Objectives: To describe characteristics of ambulatory...
7.
Trick W, Santos C, Welbel S, Tseng M, Zhang H, Donceras O, et al.
Infect Control Hosp Epidemiol . 2022 Apr; 43(12):1761-1766. PMID: 35438067
Objectives: We quantified hospital-acquired coronavirus disease 2019 (COVID-19) during the early phases of the pandemic, and we evaluated solely temporal determinations of hospital acquisition. Design: Retrospective observational study during early...
8.
Bradley M, Perez-Vilar S, Chillarige Y, Dong D, Martinez A, Weckstein A, et al.
JAMA . 2022 Apr; 327(20):2015-2018. PMID: 35394487
No abstract available.
9.
Vickers L, Martinez A, Wallem A, Johnson C, Moga D
Drugs Real World Outcomes . 2021 Jun; 8(4):519-526. PMID: 34114133
Background: With the older adult population in the USA increasing, so is the population of those with Alzheimer's disease and related dementias (ADRD). Older adults are vulnerable to the effects...
10.
Martinez A, Abner E, Jicha G, Rigsby D, Eckmann L, Huffmyer M, et al.
J Manag Care Spec Pharm . 2020 Apr; 26(4):520-528. PMID: 32223601
Background: Older adults are especially susceptible to adverse effects of inappropriate medication therapy, and anticholinergic medications are common culprits for cognitive dysfunction due to their action on the central nervous...